Author(s): Diaz Jr EM, Kies MS
This article focuses on treatment options for select skull base problems that have decreased post-treatment morbidity and, in many cases, improved survival. The select skull base cancers covered include nasopharyngeal carcinoma, squamous cell carcinoma of the paranasal sinuses, sinonasal undifferentiated carcinoma, neuroendocrine carcinoma, esthesioneuroblastoma, and salivary gland carcinoma.
Referred From: https://www.ncbi.nlm.nih.gov/pubmed/11728933
Author(s): Kokemueller H, Eckardt A, Brachvogel P, Hausamen JE
Author(s): Berdal P
Author(s): Waldron CA, El-Mofty SK, Gnepp DR
Author(s): Wakisaka S, Nonaka A, Morita Y, Fukui M, Kinoshita K
Author(s): Huang MX, MaD,SunK, YuG, GuoC,et al.
Author(s): Batsakis JG, Luna MA
Author(s): Szanto PA, Luna MA, Tortoledo ME, White RA
Author(s): Chen JC, Gnepp DR, BedrossianCW
Author(s): Lupinetti AD, Roberts DB, Williams MD, Kupferman ME, Rosenthal DI, et al.
Author(s): Chen AM, Bucci MK, Weinberg V, Garcia J, Quivey JMet al.
Author(s): Gomez DR, Hoppe BS, Wolden SL, Zhung JE, Patel SG, et al.
Author(s): Prokopakis EP, Snyderman CH, Hanna EY, Carrau RL, Johnston JT, et al.
Author(s): Garden AS, Weber RS, Morrison WH
Author(s): Mendenhall WM, Riggs CE, Vaysberg M
Author(s): Vincentelli F, Grisoli F, Leclercq TA, Ardaud B, Diaz-Vasquez P, et al.
Author(s): Fordice J, Kershaw C, El-Naggar A, Goepfert H
Author(s): Spiro RH, Hooves AG, Strong EW